Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-16 · accession 0001061983-22-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-17 | 2022-02-16 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +7,148 | 156.5K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-16 | A | A | 2,773 | $0.00 | 152,087 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-16 | A | A | 4,375 | $0.00 | 156,462 | D | — | — |